Anastrazole, Fulvestrant & Abemaciclib for HR+HER2- Metastatic Breast Cancer

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Anastrazole, Fulvestrant & Abemaciclib for HR+HER2- Metastatic Breast Cancer	Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, hormone receptor-positive breast cancer, neoplasm, skin disorder	Recruiting	Phase 2	2026-03-11		NCT05524584

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
University of California, Irvine	157

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Chao Family Comprehensive Cancer Center, University of California, Irvine	Orange	United States	24

Clinical trials